Career history of Curt Bradshaw
Former positions of Curt Bradshaw
| Companies | Position | Start | End |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 18/11/2019 | 01/11/2020 |
Tallac Therapeutics, Inc.
 Tallac Therapeutics, Inc. BiotechnologyHealth Technology Tallac Therapeutics, Inc. engages in the development of immunomodulating polynucleotides. The company is headquartered in Burlingame, CA. | Director/Board Member | 01/01/2018 | 01/01/2019 |
| Chief Tech/Sci/R&D Officer | 01/01/2018 | 01/01/2019 | |
| Founder | 01/01/2018 | 01/01/2019 | |
| President | 01/01/2018 | 01/01/2019 | |
Solstice Biologics LLC
 Solstice Biologics LLC Pharmaceuticals: MajorHealth Technology Solstice Biologics LLC develops nucleic acid therapeutics. It specializes in the development of small, cell-permeable RNAi pro-drugs. The company was founded by Steven Dowdy and Curt W. Bradshaw in 2012 and is headquartered in San Diego, CA. | Director/Board Member | 01/01/2012 | 01/01/2018 |
| Chief Tech/Sci/R&D Officer | 01/01/2012 | 01/01/2018 | |
| Founder | 01/01/2012 | 01/01/2018 | |
| Corporate Secretary | 01/01/2012 | 01/01/2018 | |
| Treasurer | 01/01/2012 | 01/01/2018 | |
Traversa Therapeutics, Inc.
 Traversa Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Traversa Therapeutics, Inc. is a biopharmaceutical company engaged in the discovery, development and commercialization of RNAi Delivery Technologies. The Company strives to rapidly advance short interfering RNA (siRNA) platform delivery technologies for use by RNAi therapeutic companies in targeting a wide variety of acute, chronic and infectious human diseases. Traversa is focused on the optimization of this platform delivery technology, as well as advancement of its own therapeutic programs for the treatment of Leukemia and Glioblastoma. The Company was founded in La Jolla, California in mid-2006, and has secured worldwide exclusive licenses to intellectual property developed during the past five years by Steven F. Dowdy, Ph.D., and his research group at the Howard Hughes Medical Institute and the University of California San Diego relating to siRNA delivery technology and induction of RNA Interference (RNAi). | Chief Tech/Sci/R&D Officer | 21/12/2009 | 19/12/2012 |
| NEUBASE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/12/2020 | - |
| LIGAND PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | - | - |
| ABBOTT LABORATORIES | Corporate Officer/Principal | - | - |
| Pfizer Asia | Corporate Officer/Principal | - | - |
Training of Curt Bradshaw
| Texas A&M University | Doctorate Degree |
Statistics
International
| United States | 10 |
Operational
| Chief Tech/Sci/R&D Officer | 5 |
| Corporate Officer/Principal | 3 |
| Director/Board Member | 2 |
Sectoral
| Health Technology | 7 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
| ARROWHEAD PHARMACEUTICALS, INC. | Health Technology |
| NEUBASE THERAPEUTICS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Traversa Therapeutics, Inc.
Traversa Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Traversa Therapeutics, Inc. is a biopharmaceutical company engaged in the discovery, development and commercialization of RNAi Delivery Technologies. The Company strives to rapidly advance short interfering RNA (siRNA) platform delivery technologies for use by RNAi therapeutic companies in targeting a wide variety of acute, chronic and infectious human diseases. Traversa is focused on the optimization of this platform delivery technology, as well as advancement of its own therapeutic programs for the treatment of Leukemia and Glioblastoma. The Company was founded in La Jolla, California in mid-2006, and has secured worldwide exclusive licenses to intellectual property developed during the past five years by Steven F. Dowdy, Ph.D., and his research group at the Howard Hughes Medical Institute and the University of California San Diego relating to siRNA delivery technology and induction of RNA Interference (RNAi). | Commercial Services |
| Pfizer Asia | |
Solstice Biologics LLC
Solstice Biologics LLC Pharmaceuticals: MajorHealth Technology Solstice Biologics LLC develops nucleic acid therapeutics. It specializes in the development of small, cell-permeable RNAi pro-drugs. The company was founded by Steven Dowdy and Curt W. Bradshaw in 2012 and is headquartered in San Diego, CA. | Health Technology |
Tallac Therapeutics, Inc.
Tallac Therapeutics, Inc. BiotechnologyHealth Technology Tallac Therapeutics, Inc. engages in the development of immunomodulating polynucleotides. The company is headquartered in Burlingame, CA. | Health Technology |
- Stock Market
- Insiders
- Curt Bradshaw
- Experience